Client Login | Refer a Friend | Search | Enroll Now | Free Info Kit

What is Cord Blood? What are Stem Cells? Diseases Treated Family Banking & Public Donation Real People, Real Stories Medical Testimonials Rights & Legislation Science & Research

Most Experienced Collection & Processing Corporate Stability Secure Facility Quality Service Research & Innovation One-Step Shipping Our Pricing Real People, Real Stories Families in Need

Cord Blood Stem Cells Banking Cord Blood Collecting Cord Blood Shipping and Handling Processing and Banking About CBR Enrolling With CBR Common Misconceptions

Log In/Create Account Account Summary Before My Due Date My Resources Refer A Friend Gift Registry CBR Moms Stay Connected Help

About Cord Blood Banking Why Cord Blood Registry? Principles in Action® Testimonials Common Misconceptions FAQs Request Materials Educational Programs Video Demonstration

Company Overview Newsroom CBR Newsletters Media Resources Career Opportunities Contact Us

About Us

Company Overview

Newsroom

Press Releases

Stem Cell News and Research

"The use of umbilical cord blood stem cells in the treatment of disease is one of the most prominent advancements in medicine today. Developments in this field will revolutionize medicine and disease treatment."

Roger Markwald M.D. Professor of Cell Biology, Medical University of South Carolina

Adult Stem Cell Research Breakthrough Produces Insulin for Diabetics

By Steven Ertelt
LifeNews.com Editor
July 10, 2006

A scientist in Ireland has made a major breakthrough in the field of adult stem cell research by producing insulin needed by diabetic patients from the stem cells from the umbilical cords of living babies. The result provides real hope for diabetics because the insulin from embryonic stem cells doesn't work as effectively and involves the destruction of human life.

Colin McGuckin, professor of regenerative medicine at the University of Newcastle, will soon present the findings to Catholic church leaders at a presentation at the Augustinian Institute in Rome.

"We have been able to produce insulin-secreting cells from cord blood, which is pretty much a first," McGuckin told the London Times.

McGuckin said that insulin produced from adult stem cells will be more effective for those with diabetes.

"Although people have been able to do it from embryonic stem cells, they are not transplantable because they don't have a tissue match for the patient. Cord blood gives a big advantage," he explained.

McGuckin also told the Times that the process is so effective that embryonic stem cells are not needed altogether.

"We are able to produce many different tissues from cord blood stem cells so we are really the first to rival embryonic stem cells," he said.

While scientists must destroy human life to obtain embryonic stem cells, McGuckin says they're in ready supply from a newborn's umbilical cord and its blood and able to be find in specific matches for patients.

"Ultimately we will be able to achieve the same result from non-embryonic stem cells. Some 100 million children are born every year, that is an awful lot of stem cells if you want to find a tissue type that matches you," he said.

Meanwhile, embryonic stem cell transplants also have problems with cancers and tumors afterwards, but McGuckin said that's not the case with adult stem cells from the umbilical cord.

McGuckin also told the Times that a little bit of umbilical cord blood goes a long way. He indicated that storing the blood from just one baby born out of 5,000 would ensure enough adult stem cells for the entire population.

------------------------------------------------------------------------

View News & Media Disclaimer